The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
The Risks and Benefits of Myopia Control
Open accessAbstract
PURPOSE: The prevalence of myopia is increasing around the world, stimulating interest in methods to slow its progression. The primary justification for slowing myopia progression is to reduce the risk of vision loss through sight-threatening ocular pathologic features in later life. The article analyzes whether the potential benefits of slowing myopia progression by 1 diopter (D) justify the potential risks associated with treatments. METHODS: First, the known risks associated with various methods of myopia control are summarized, with emphasis on contact lens wear. Based on available data, the risk of visual impairment and predicted years of visual impairment are estimated for a range of incidence levels. Next, the increased risk of potentially sight-threatening conditions associated with different levels of myopia are reviewed. Finally, a model of the risk of visual impairment as a function of myopia level is developed, and the years of visual impairment associated with various levels of myopia and the years of visual impairment that could be prevented with achievable levels of myopia control are estimated. RESULTS: Assuming an incidence of microbial keratitis between 1 and 25 per 10 000 patient-years and that 15% of cases result in vision loss leads to the conclusion that between 38 and 945 patients need to be exposed to 5 years of wear to produce 5 years of vision loss. Each additional 1 D of myopia is associated with a 58%, 20%, 21%, and 30% increase in the risk of myopic maculopathy, open-angle glaucoma, posterior subcapsular cataract, and retinal detachment, respectively. The predicted mean years of visual impairment ranges from 4.42 in a person with myopia of -3 D to 9.56 in a person with myopia of -8 D, and a 1-D reduction would lower these by 0.74 and 1.21 years, respectively. CONCLUSIONS: The potential benefits of myopia control outweigh the risks: the number needed to treat to prevent 5 years of visual impairment is between 4.1 and 6.8, whereas fewer than 1 in 38 will experience a loss of vision as a result of myopia control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.006 · Cited by 5,500
Kass, M. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.701 · Cited by 3,705
Morgan, I. G., Ohno-Matsui, K., & Saw, S.-M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60272-4 · Cited by 1,871
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
The Complications of Myopia: A Review and Meta-Analysis
Haarman, A. E. G., Enthoven, C. A., Tideman, J. W. L., Tedja, M. S., Verhoeven, V. J. M., & Klaver, C. C. W. (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.4.49 · Cited by 881
International Photographic Classification and Grading System for Myopic Maculopathy
Ohno-Matsui, K., Kawasaki, R., Jonas, J. B., Cheung, C. M. G., Saw, S.-M., Verhoeven, V. J. M., Klaver, C. C. W., Moriyama, M., Shinohara, K., Kawasaki, Y., et al. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.01.022 · Cited by 866
Chia, A., Chua, W.-H., Cheung, Y.-B., Wong, W.-L., Lingham, A., Fong, A., & Tan, D. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.031 · Cited by 852
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Visual Acuity and the Causes of Visual Loss in Australia
Attebo, K., Mitchell, P., & Smith, W. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30684-2 · Cited by 795
Wong, T. Y., Ferreira, A., Hughes, R., Carter, G., & Mitchell, P. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.08.010 · Cited by 758
Metadata
- Authors
- Bullimore, M. A., Ritchey, E. R., Shah, S., Leveziel, N., Bourne, R. R. A., & Flitcroft, D. I.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 128
- Issue
- 11
- Pages
- 1561-1579
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W3159823987
- Cited by
- 321
- References
- 90
- FWCI
- 26.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Risks and Benefits of Myopia Control. https://app.cochat.ai/papers/10.1016/j.ophtha.2021.04.032
- The paper
- Bullimore, M. A., Ritchey, E. R., Shah, S., Leveziel, N., Bourne, R. R. A., & Flitcroft, D. I. (2021). The Risks and Benefits of Myopia Control. Ophthalmology. https://doi.org/10.1016/j.ophtha.2021.04.032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.